Evidence map›Paper›PMID 40642770›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Cross-border spread of a mosaic resistance (OXA-48) and virulence (aerobactin) plasmid in

Marius Linkevicius, Erik Alm, Louise Roer, Olov Svartström, Maria Dada-Olorunwa, Kati Räisänen, Felix Reichert, Sophie Möller, Christina Clarke, Martin Cormican and 13 more

Erratum issuedAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Emergence of ST383 carbapenem-resistantJAC-antimicrobial resistance · 2026
    Article
  3. Article
  4. Article
  5. International spread or local outbreak? Epidemiologic analyses of transmission patterns of NDM-1-producingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Marius LinkeviciusEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Erik AlmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Louise RoerNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Olov SvartströmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Maria Dada-OlorunwaEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Kati RäisänenFinnish Institute for Health and Welfare, Helsinki, Finland.
Felix ReichertDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Sophie MöllerGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Christina ClarkeGalway Reference Laboratory Service, Galway University Hospital, Galway, Ireland.
Martin CormicanSchool of Medicine, University of Galway, Galway, Ireland.
Baiba Niedre-OtomereNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases", Laboratory Service, Riga East University Hospital, Riga, Latvia.
Reinis VangravsNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases", Laboratory Service, Riga East University Hospital, Riga, Latvia.
Paulius GreičiusNational Public Health Surveillance Laboratory, Vilnius, Lithuania.
Olga BurduniucNational Agency for Public Health, Ministry of Health, Chisinau, Moldova.
Maria AntonNational Agency for Public Health, Ministry of Health, Chisinau, Moldova.
Antoni P A HendrickxCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Sandra WitteveenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Vilhelm MüllerPublic Health Agency of Sweden, Solna, Sweden.
Daniel PalmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Diamantis PlachourasEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Dominique L MonnetEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Henrik HasmanNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Anke KohlenbergEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An investigation of the European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) detected the same mosaic IncHI1B(pNDM-MAR) resistance (OXA-48) and virulence (aerobactin) plasmid in 492

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, BacterialHydroxamic AcidsKlebsiella InfectionsKlebsiella pneumoniaePlasmidsDisease OutbreaksDrug Resistance, Multiple, BacterialEuropeHumansMicrobial Sensitivity TestsVirulenceaerobactinAnti-Bacterial Agentsbeta-LactamasesHydroxamic Acidsantimicrobial resistanceCarbapenemase-producing Enterobacteralescross-border spreadsurveillancevirulencewhole genome sequencing

Identifiers

PMID40642770
PMCPMC12262110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.